Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Fidia Spa ( (IT:FDA) ) has shared an update.
Fidia has announced the conversion of six bonds from the second tranche of its convertible bond loan reserved for Global Growth Holding Limited, resulting in the issuance of 666,666 new shares at a price of €0.09 each. The new shares are admitted to trading on the regulated market under the existing prospectus, completing the conversion of all subscribed bonds under this tranche.
Following this operation, the capital increase linked to the convertible loan reaches a fully subscribed nominal amount of €500,000, with no remaining subscribed but unconverted bonds outstanding. As a result, Fidia’s share capital rises by €60,000 to €10,347,761.90, and the total number of shares increases to 35,742,927, marking a completed step in the company’s financing and capital-structure adjustment plan.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global player in numerical control technology and high-performance integrated milling systems. Its solutions, including numerical controls, high-speed milling machines and CAM software, are mainly used in the automotive mould sector and in aerospace, covering the entire milling process from programming to finished part.
Average Trading Volume: 964,804
Technical Sentiment Signal: Strong Sell
Current Market Cap: €3.3M
For an in-depth examination of FDA stock, go to TipRanks’ Overview page.